Comparison 13. E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Clinical resolution of the infection | 1 | 108 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.13 [0.88, 1.47] |
2 Adverse effects | 1 | 108 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.82 [0.89, 3.72] |
3 Amputations | 1 | 108 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.11 [0.01, 1.94] |